𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of Neck Dissection in the Management of Isolated Nodal Recurrence after Head and Neck Cancer Treatment

✍ Scribed by Jimmy Yu–wai Chan

Book ID
120891883
Publisher
Current Science Inc.
Year
2013
Tongue
English
Weight
104 KB
Volume
15
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolated neck recurrence after definitiv
Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: Salvage in the dissected or undissected neck
✍ Stanley L. Liauw; Robert J. Amdur; Christopher G. Morris; John W. Werning; Dougl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## Background. The role of salvage neck dissection for isolated regional recurrences after definitive radiotherapy (RT) is ill‐defined. ## Methods. Five‐hundred fifty patients were treated with RT for lymph node–positive head and neck cancer. RT consisted of a median dose of 74.4 Gy.

Efficacy of salvage neck dissection for
Efficacy of salvage neck dissection for isolated nodal recurrences in early carcinoma of oral tongue with watchful waiting management of initial N0 neck
✍ Raymond King Yin Tsang; Joseph Chun Kit Chung; Victor Shing Howe To; Jimmy Yu Wa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract ## Background Recent studies have shown that salvage treatment may be effective for early tongue carcinoma with nodal failures after watchful waiting policy. We wanted to assess the efficacy of salvage neck dissection. ## Methods We conducted a retrospective review of all patients wi

Recurrent head and neck cancer: The resu
Recurrent head and neck cancer: The results of treatment
✍ R. G. Williams 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

## Abstract A study of 144 patients with cancer of the head and neck showed that 67 (46 per cent) developed recurrent cancer. Radical second treatment, almost exclusively by surgery, secured an 11 out of 67 or 16 per cent crude 5-year survival rate for recurrent head and neck cancer. Further analys